AU5084300A - New vaccine formulations - 1 - Google Patents

New vaccine formulations - 1

Info

Publication number
AU5084300A
AU5084300A AU50843/00A AU5084300A AU5084300A AU 5084300 A AU5084300 A AU 5084300A AU 50843/00 A AU50843/00 A AU 50843/00A AU 5084300 A AU5084300 A AU 5084300A AU 5084300 A AU5084300 A AU 5084300A
Authority
AU
Australia
Prior art keywords
vaccine formulations
new vaccine
new
formulations
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50843/00A
Inventor
Haj Chana
Peter Smith
Darren Stevenson
Andrew Sutton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Onyvax Ltd
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Publication of AU5084300A publication Critical patent/AU5084300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/884—Vaccine for a specifically defined cancer prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU50843/00A 1999-05-21 2000-05-19 New vaccine formulations - 1 Abandoned AU5084300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9911823.4A GB9911823D0 (en) 1999-05-21 1999-05-21 New vaccine formulations
GB9911823 1999-05-21
PCT/GB2000/001938 WO2000071157A2 (en) 1999-05-21 2000-05-19 New vaccine formulations - 1

Publications (1)

Publication Number Publication Date
AU5084300A true AU5084300A (en) 2000-12-12

Family

ID=10853879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50843/00A Abandoned AU5084300A (en) 1999-05-21 2000-05-19 New vaccine formulations - 1

Country Status (5)

Country Link
EP (1) EP1178823A2 (en)
AU (1) AU5084300A (en)
CA (1) CA2373730A1 (en)
GB (1) GB9911823D0 (en)
WO (1) WO2000071157A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030108574A1 (en) * 2001-08-21 2003-06-12 Jennings Harold J. Carbohydrate-based whole cell cancer vaccines
EP2710037B1 (en) * 2011-05-19 2019-07-31 The Regents of The University of Michigan Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191784T3 (en) * 1995-12-28 2003-09-16 Univ Johns Hopkins Med TUMORS VACCINES OF ALOGENIC PARACRINE CITOCINES.
CA2245099C (en) * 1996-02-02 2007-01-09 Suzanne L. Topalian Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
US5804443A (en) * 1997-02-28 1998-09-08 Bernofsky; Carl Human monocytic leukemia cell line

Also Published As

Publication number Publication date
WO2000071157A2 (en) 2000-11-30
EP1178823A2 (en) 2002-02-13
CA2373730A1 (en) 2000-11-30
GB9911823D0 (en) 1999-07-21
WO2000071157A3 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU5977700A (en) Vaccines
AU7514700A (en) Cyanopiperidines
AU6440900A (en) Homogentisate-dioxygenase
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU1600401A (en) Malaria vaccine
AU6158700A (en) Vaccine
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU4561600A (en) Benzofuranylaminoalcohols
AU5811600A (en) Vaccine
AU1901801A (en) Glucofuranoses
AU4435300A (en) Hula-hoop
AU7303400A (en) Osseo-distractor
AU1915601A (en) Periotome
AU7513400A (en) Hydantoin-racemase
AU2582200A (en) Windturbine
AU5084300A (en) New vaccine formulations - 1
AU5416100A (en) Retinoscopes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase